Inspection Record

Apotheca, Inc — FDA 483 Findings

US FDAInspected 2015-07-28Published 2024-01-17 6 findingsDocumentation and recordsProcess validationQuality unit oversightDeviation, CAPA, and investigation

Inspectors David L Miser · Brent T. HallThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Documentation and records

08/19/2008 - 08/28/2008* FE/NUMBER 1931484 TYPE ESTABUSHMENT INSPECTED Homeopathic Drug Manufacturing Batch production and control records do not include the results ofany investigation made into any unexplained discrepancy, whether or not the batch of drug product had already been distributed.

2Process validation

Control procedures are not established which validate the perfonnance ofthose manufacturing processes that may be responsible for causing variability in the characteristics ofin-process material and the drug product.

3Documentation and records

08/19/2008 - 08/28/2008* FE NUMBER 1931484 STREET AOORESS 313 Lowrey Dr 1i'PE ESTAllUSHMENT INSPECTED Homeopathic Drug Manufacturing Batch production and control records do not include the identity ofindividual major equipment used for each batch ofdrug product produced.

4Quality unit oversight

Each lot of components, drug product containers, and closures is not withheld from use until the lot has been sampled, tested, examined, and released by the quality control unit.

5Deviation, CAPA, and investigation

08/19/2008 - 08/28/2008* FElNUMBER 1931484 TYPE ESTASUSHMENT INSPECTED Homeopathic Drug Manufacturing Investigations ofan unexplained discrepancy did not extend to other batches ofthe same drug product and other drug products that may have been associated with the specific failure or discrepancy.

6Documentation and records

08/19/2008 - 08/28/2008* FE/NUMBER 1931484 TYPE ESTABLISHMENT INSPECTED Homeopathic Drug Manufacturing Batch production and control records do not include the results of any investigation made into any unexplained discrepancy, whether or not the batch of drug product had already been distributed.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Apotheca, Inc company profile — full history US FDA documents, 2024 Go to Findings search